The utility of parent's and teacher's concerns for the screening of speech sound disorders: A study on French-speaking preschool children.

Speech sound disorders (SSD) are associated with difficulties in communication, social participation, literacy, and learning. An early identification process is therefore necessary. Our study was aimed at determining the utility and accuracy of parent's and teacher's concerns in screening for SSD.

Spatial unfolding of an extended La-140 source within a 0.5 km-wide exclusion zone using Compton gamma imaging measurements.

Results from applying an advanced spatial-unfolding technique to outdoor-trial data acquired with a Silicon photomultiplier-based Compton Telescope for Safety and Security (SCoTSS) gamma imager during perimeter survey of a distributed La-140 source lying within a 500 m x 500 m exclusion zone are presented. A synthetic-data version of the experiment was also modelled using Monte Carlo simulations and reconstructed. For both experimental and synthetic data the method faithfully reproduces the shape of the activity distribution, and for synthetic data the total activity is reproduced as well.

Participatory research in child psychology & psychiatry: Embracing untidiness to break new ground.

We are pleased to present our Special Issue on Participatory Research. In this editorial, we outline how the disability rights movement has been instrumental to the development of participatory approaches, before giving consideration to some of the debates and criticisms associated with participatory research in practice. We summarise the contributions offered by the studies within this issue and propose four areas of consideration, drawn from the body of included research, to inform future developments.

Novel Macrocyclic NLRP3 Inhibitors.

Aberrant activation of NLRP3 due to persistent tissue damage, misfolded proteins or crystal deposits has been linked to multiple chronic inflammatory disorders such as cryopyrin-associated periodic syndrome (CAPS), neurodegenerative diseases, gouty arthritis, and numerous others. Hence, there has been an increasing interest in NLRP3 inhibitors as therapeutics. A first generation of NLRP3 inhibitors bearing a sulfonylurea core such as MCC950 (developed by Pfizer) were discovered by phenotypic screening, however their mode of action was only elucidated later.